SUPERLUMINAL MEDICINES Trademark
Trademark Overview
On Friday, October 6, 2023, a trademark application was filed for SUPERLUMINAL MEDICINES with the United States Patent and Trademark Office. The USPTO has given the SUPERLUMINAL MEDICINES trademark a serial number of 98212701. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, August 29, 2025. This trademark is owned by Superluminal Medicines, Inc.. The SUPERLUMINAL MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors
Development of pharmaceutical preparations and medicines
General Information
| Serial Number | 98212701 |
| Word Mark | SUPERLUMINAL MEDICINES |
| Filing Date | Friday, October 6, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Friday, August 29, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 9, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors |
| NOT AVAILABLE | "MEDICINES" |
| Goods and Services | Development of pharmaceutical preparations and medicines |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Superluminal Medicines, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02116 |
| Party Name | Superluminal Medicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02116 |
Trademark Events
| Event Date | Event Description |
| Tuesday, October 10, 2023 | NEW APPLICATION ENTERED |
| Saturday, October 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 28, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, June 4, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 4, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 4, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, June 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 4, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 3, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 3, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, March 3, 2025 | SOU EXTENSION 1 FILED |
| Monday, March 3, 2025 | SOU EXTENSION 1 GRANTED |
| Tuesday, March 4, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 29, 2025 | SOU EXTENSION 2 FILED |
| Friday, August 29, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 29, 2025 | SOU EXTENSION 2 GRANTED |
| Monday, September 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, June 19, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 9, 2024 | PUBLISHED FOR OPPOSITION |
